Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chronic Liver Diseases and the Microbiome—Translating Our Knowledge of Gut Microbiota to Management of Chronic Liver Disease
Chathur Acharya, Jasmohan S. Bajaj
Gastroenterology (2020) Vol. 160, Iss. 2, pp. 556-572
Open Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

Liver cirrhosis
Pere Ginès, Aleksander Krag, Juan G. Abraldeṣ, et al.
The Lancet (2021) Vol. 398, Iss. 10308, pp. 1359-1376
Closed Access | Times Cited: 932
Gut-liver axis: Pathophysiological concepts and clinical implications
Herbert Tilg, Timon E. Adolph, Michael Trauner
Cell Metabolism (2022) Vol. 34, Iss. 11, pp. 1700-1718
Open Access | Times Cited: 340
Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure
Jonel Trebicka, Peer Bork, Aleksander Krag, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 18, Iss. 3, pp. 167-180
Closed Access | Times Cited: 144
The anti-inflammatory effects of Akkermansia muciniphila and its derivates in HFD/CCL4-induced murine model of liver injury
Shahrbanoo Keshavarz Azizi Raftar, Fatemeh Ashrafian, Sara Abdollahiyan, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 63
Gut microbiome dysbiosis is associated with increased mortality after solid organ transplantation
J. Casper Swarte, Yanni Li, Shixian Hu, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 660
Open Access | Times Cited: 60
Microbiome therapeutics for hepatic encephalopathy
Patricia P. Bloom, Elliot B. Tapper, Vincent B. Young, et al.
Journal of Hepatology (2021) Vol. 75, Iss. 6, pp. 1452-1464
Open Access | Times Cited: 55
The microbiota and the gut–liver axis in primary sclerosing cholangitis
Johannes R. Hov, Tom H. Karlsen
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 20, Iss. 3, pp. 135-154
Closed Access | Times Cited: 53
Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – April 2022 – AWMF-Registernummer: 021–025
Elke Roeb, Ali Canbay, Frank Tacke, et al.
Zeitschrift für Gastroenterologie (2022) Vol. 60, Iss. 09, pp. 1346-1421
Open Access | Times Cited: 51
Fecal Microbiota Transplantation in Liver Cirrhosis
Adrian Boicean, Victoria Bîrluțiu, Cristian Ichim, et al.
Biomedicines (2023) Vol. 11, Iss. 11, pp. 2930-2930
Open Access | Times Cited: 29
Hepatic Fibrosis and Cancer: The Silent Threats of Metabolic Syndrome
Scott L. Friedman
Diabetes & Metabolism Journal (2024) Vol. 48, Iss. 2, pp. 161-169
Open Access | Times Cited: 14
Regulatory mechanism of HIF-1α and its role in liver diseases: a narrative review
Qingfei Chu, Xinyu Gu, Qiuxian Zheng, et al.
Annals of Translational Medicine (2021) Vol. 10, Iss. 2, pp. 109-109
Open Access | Times Cited: 46
NLRP3 Inflammasome in Acute and Chronic Liver Diseases
Katia Sayaf, Sara Battistella, Francesco Paolo Russo
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4537-4537
Open Access | Times Cited: 5
Survival Benefits of Transarterial Chemoembolization Plus Ablation Therapy in Patients With Intermediate or Advanced Hepatocellular Carcinoma: A Propensity Score Matching Study
Jingyi Dai, Yadi Ding, Qiaomei Zheng, et al.
Cancer Management and Research (2025) Vol. Volume 17, pp. 483-497
Open Access
Modulation of the Bile Acid Enterohepatic Cycle by Intestinal Microbiota Alleviates Alcohol Liver Disease
Dragos Ciocan, Madeleine Spatz, Nicolas Trainel, et al.
Cells (2022) Vol. 11, Iss. 6, pp. 968-968
Open Access | Times Cited: 25
Age-Related NAFLD: The Use of Probiotics as a Supportive Therapeutic Intervention
Lucrezia Irene Maria Campagnoli, Nicoletta Marchesi, Mariapia Vairetti, et al.
Cells (2022) Vol. 11, Iss. 18, pp. 2827-2827
Open Access | Times Cited: 24
Liver Regeneration and Immunity: A Tale to Tell
Nicola Di-Iacovo, Stefania Pieroni, Danilo Piobbico, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1176-1176
Open Access | Times Cited: 15
Longitudinal gut fungal alterations and potential fungal biomarkers for the progression of primary liver disease
Shiman Jiang, Lvwan Xu, Yanfei Chen, et al.
Science China Life Sciences (2024) Vol. 67, Iss. 6, pp. 1183-1198
Open Access | Times Cited: 4
Litchi induced liver inflammation: Investigating litchi thaumatin-like protein metabolic kinetics in mice
Wenhua Li, Shiai Zeng, Kai Wang, et al.
Food Chemistry (2025), pp. 144012-144012
Closed Access
Ginsenoside Rk3 Suppresses Hepatocellular Carcinoma Development through Targeting the Gut-Liver Axis
Linlin Qu, Xiaoxuan Ma, Daidi Fan
Journal of Agricultural and Food Chemistry (2021) Vol. 69, Iss. 35, pp. 10121-10137
Closed Access | Times Cited: 28
Updated S2k Clinical Practice Guideline on Non-alcoholic Fatty Liver Disease (NAFLD) issued by the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS) – April 2022 – AWMF Registration No.: 021–025

Zeitschrift für Gastroenterologie (2022) Vol. 60, Iss. 09, pp. e733-e801
Open Access | Times Cited: 21
Gut Dysbiosis and Blood-Brain Barrier Alteration in Hepatic Encephalopathy: From Gut to Brain
Ali Shahbazi, Ali Sepehrinezhad, Edris Vahdani, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1272-1272
Open Access | Times Cited: 11
Gastrointestinal disorders and intestinal bacteria: Advances in research and applications in therapy
Toshifumi� Ohkusa, Yuriko Nishikawa, Nobuhiro Sato
Frontiers in Medicine (2023) Vol. 9
Open Access | Times Cited: 10
Avenues within the gut-liver-brain axis linking chronic liver disease and symptoms
Henry H. Nguyen, Mark G. Swain
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 10
Gut microbiota-modulating agents in alcoholic liver disease: Links between host metabolism and gut microbiota
Jang Han Jung, Sung Eun Kim, Ki Tae Suk, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 17
Antibiotics Attenuate Methamphetamine-Induced Hepatotoxicity by Regulating Oxidative Stress and TLR4/MyD88/Traf6 Axis
Lijian Chen, Jie-Tao He, Ming Pan, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top